Jennifer Walsh and Adria Warren Discuss Oncology Payment Landscape at ACCC
10 March 2023
The American Journal of Managed Care
Foley & Lardner LLP Public Affairs Director Jennifer Walsh and Partner Adria Warren are quoted in The American Journal of Managed Care article, “Stops and Starts Abound in the Oncology Payment Landscape,” discussing updates and considerations around several policies surrounding cancer treatment and the financial aspects of care.
Their comments provide an overview of Cures 2.0, the No Surprises Act, and the 340B drug pricing program, and are taken from their presentation at the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Business Summit on the topic of “Emergent Payment Issues in Oncology.”
People
Related News
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."
08 October 2024
In the News
Anil Shankar Shares Insight on Proposition 34, Impact to 340B Program
Foley & Lardner LLP partner Anil Shankar offered insight on California's Proposition 34, a ballot measure this election season, in the KCRW article, "Confused on Prop 34? It’s about the politics of rent control."